A double blind,randomised, placebo controlled study of�Ro�64-0796 (also known as GS4104) in the treatment of influenza infection

Roche

Description

Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.

Citations (0)

Mentions (0)

Metrics

Dataset Index

0.2

FAIR Score

31%

Citations

0

Mentions

0

Metrics Over Time

Publication Details

DOI

Publisher

Vivli

License

Study data may be accessed by completing a request form at https://vivli.org. It will then be reviewed according to the data contributor’s governance policy, see https://vivli.org/members/ourmembers/ for Vivli member’s review process. If approved, use of the data is governed by the data use agreement at https://vivli.org/resources/vivli-data-use-agreement/

Assigned Domain

Subfield

Information Systems

Field

Computer Science

Domain

Physical Sciences

Confidence Score

43%

Source

Scholar Data Model

Keywords

Conditions: influenzaInterventions: oseltamivir

Normalization Factors

FT

51.92

CTw

1.00

MTw

1.00